Literature DB >> 19560356

Developing standard procedures for murine and canine efficacy studies of DMD therapeutics: report of two expert workshops on "Pre-clinical testing for Duchenne dystrophy": Washington DC, October 27th-28th 2007 and Zürich, June 30th-July 1st 2008.

Kanneboyina Nagaraju1, Raffaella Willmann.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19560356      PMCID： PMC2766092          DOI： 10.1016/j.nmd.2009.05.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  3 in total

Review 1.  Mammalian animal models for Duchenne muscular dystrophy.

Authors:  Raffaella Willmann; Stefanie Possekel; Judith Dubach-Powell; Thomas Meier; Markus A Ruegg
Journal:  Neuromuscul Disord       Date:  2009-02-12       Impact factor: 4.296

2.  Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures.

Authors:  Christopher F Spurney; Heather Gordish-Dressman; Alfredo D Guerron; Arpana Sali; Gouri S Pandey; Rashmi Rawat; Jack H Van Der Meulen; Hee-Jae Cha; Emidio E Pistilli; Terence A Partridge; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  Muscle Nerve       Date:  2009-05       Impact factor: 3.217

Review 3.  Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Miranda D Grounds; Hannah G Radley; Gordon S Lynch; Kanneboyina Nagaraju; Annamaria De Luca
Journal:  Neurobiol Dis       Date:  2008-04-09       Impact factor: 5.996
  3 in total
  18 in total

1.  In vivo canine muscle function assay.

Authors:  Martin K Childers; Robert W Grange; Joe N Kornegay
Journal:  J Vis Exp       Date:  2011-04-05       Impact factor: 1.355

2.  SMASH - semi-automatic muscle analysis using segmentation of histology: a MATLAB application.

Authors:  Lucas R Smith; Elisabeth R Barton
Journal:  Skelet Muscle       Date:  2014-11-27       Impact factor: 4.912

3.  Enhancing translation: guidelines for standard pre-clinical experiments in mdx mice.

Authors:  Raffaella Willmann; Annamaria De Luca; Michael Benatar; Miranda Grounds; Judith Dubach; Jean-Marc Raymackers; Kanneboyina Nagaraju
Journal:  Neuromuscul Disord       Date:  2011-07-06       Impact factor: 4.296

4.  Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Emidio E Pistilli; Sasha Bogdanovich; Marcus D Goncalves; Rexford S Ahima; Jennifer Lachey; Jasbir Seehra; Tejvir Khurana
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 5.  Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus.

Authors:  Gianina Ravenscroft; Nigel G Laing; Carsten G Bönnemann
Journal:  Brain       Date:  2014-12-31       Impact factor: 13.501

6.  Questions Answered and Unanswered by the First CRISPR Editing Study in a Canine Model of Duchenne Muscular Dystrophy.

Authors:  Nalinda B Wasala; Chady H Hakim; Shi-Jie Chen; N Nora Yang; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2019-02-26       Impact factor: 5.695

Review 7.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

8.  Gait disturbances in dystrophic hamsters.

Authors:  Thomas G Hampton; Ajit Kale; Ivo Amende; Wenlong Tang; Scott McCue; Hemmi N Bhagavan; Case G VanDongen
Journal:  J Biomed Biotechnol       Date:  2011-01-13

9.  The different impact of a high fat diet on dystrophic mdx and control C57Bl/10 mice.

Authors:  Hannah G Radley-Crabb; Marta L Fiorotto; Miranda D Grounds
Journal:  PLoS Curr       Date:  2011-11-15

Review 10.  The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development.

Authors:  Emma Heslop; Cristina Csimma; Volker Straub; John McCall; Kanneboyina Nagaraju; Kathryn R Wagner; Didier Caizergues; Rudolf Korinthenberg; Kevin M Flanigan; Petra Kaufmann; Elizabeth McNeil; Jerry Mendell; Sharon Hesterlee; Dominic J Wells; Kate Bushby
Journal:  Orphanet J Rare Dis       Date:  2015-04-23       Impact factor: 4.123
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.